# Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney

> **NCT00035555** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 230 (actual)

## Conditions studied

- Graft Rejection
- Kidney Transplantation
- Renal Transplantation

## Interventions

- **DRUG:** Belatacept
- **DRUG:** Cyclosporine
- **DRUG:** Mycophenolate mofetil (MMF)
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT00035555
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2004-01
- **Final completion:** 2012-07
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2014-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035555, "Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00035555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*